T1	Participants 319 371	patients with 1 but not 2 or 3 brain metastasis (BM)
T2	Participants 715 738	252 of the 331 patients
T3	Participants 793 829	Breast cancer patients were excluded
T4	Participants 772 792	211 had lung cancer.
